ONEM insider filings
1Life Healthcare Inc — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-02-24. Screen ONEM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ONEM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — 1Life Healthcare Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-02-24 | 4 | Thaler Bjorn B — Chief Financial Officer | Disposition to issuer (D): 21,532 @ $18 · Disposition to issuer (D): 52,083 (derivative) · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 108,182 (derivative) · Disposition to issuer (D): 108,834 (derivative) · Disposition to issuer (D): 209,164 (derivative) · +5 more | EDGAR |
| 2023-02-24 | 4 | Rubin Amir Dan — Chair, CEO and President, Director | Disposition to issuer (D): 99,748 @ $18 · Disposition to issuer (D): 2,064,765 (derivative) · Disposition to issuer (D): 8,645,823 (derivative) · Disposition to issuer (D): 583,090 (derivative) · Disposition to issuer (D): 477,612 (derivative) | EDGAR |
| 2023-02-24 | 4 | Mango Lisa A — General Counsel and Secretary | Disposition to issuer (D): 88,385 @ $18 · Disposition to issuer (D): 3,750 (derivative) · Disposition to issuer (D): 12,870 (derivative) · Disposition to issuer (D): 55,000 (derivative) · Disposition to issuer (D): 19,222 (derivative) · Disposition to issuer (D): 42,325 (derivative) · +7 more | EDGAR |
| 2023-02-24 | 4 | Diamond Andrew S — Chief Medical Officer | Disposition to issuer (D): 23,620 @ $18 · Disposition to issuer (D): 26,032 (derivative) · Disposition to issuer (D): 33,860 (derivative) · Disposition to issuer (D): 74,702 (derivative) · Disposition to issuer (D): 96,420 (derivative) · Disposition to issuer (D): 3,553 (derivative) · +4 more | EDGAR |
| 2023-02-24 | 4 | Agarwal Vikas — Chief Accounting Officer | Disposition to issuer (D): 8,866 @ $18 · Disposition to issuer (D): 3,116 (derivative) · Disposition to issuer (D): 1,658 (derivative) · Disposition to issuer (D): 3,240 (derivative) · Disposition to issuer (D): 12,907 (derivative) · Disposition to issuer (D): 16,950 (derivative) · +2 more | EDGAR |
| 2023-02-24 | 4 | Lewis-Hall Freda C — Director | Disposition to issuer (D): 4,534 @ $18 · Disposition to issuer (D): 10,381 (derivative) · Disposition to issuer (D): 5,294 (derivative) · Disposition to issuer (D): 20,728 (derivative) | EDGAR |
| 2023-02-24 | 4 | Kennedy David P — Director | Disposition to issuer (D): 10,285 @ $18 · Disposition to issuer (D): 250,779 @ $18 · Disposition to issuer (D): 10,462 (derivative) · Disposition to issuer (D): 984 (derivative) · Disposition to issuer (D): 5,294 (derivative) · Disposition to issuer (D): 498 (derivative) · +4 more | EDGAR |
| 2023-02-24 | 4 | Kalen Holmes — Director | Disposition to issuer (D): 4,534 @ $18 · Disposition to issuer (D): 13,617 (derivative) · Disposition to issuer (D): 10,462 (derivative) · Disposition to issuer (D): 5,294 (derivative) · Disposition to issuer (D): 20,728 (derivative) | EDGAR |
| 2023-02-24 | 4 | Blumenkranz Mark S. — Director | Disposition to issuer (D): 4,534 @ $18 · Disposition to issuer (D): 10,381 (derivative) · Disposition to issuer (D): 5,294 (derivative) · Disposition to issuer (D): 20,728 (derivative) | EDGAR |
| 2023-02-24 | 4 | Auvil Paul R. III — Director | Disposition to issuer (D): 12,586 @ $18 · Disposition to issuer (D): 10,462 (derivative) · Disposition to issuer (D): 984 (derivative) · Disposition to issuer (D): 5,294 (derivative) · Disposition to issuer (D): 498 (derivative) · Disposition to issuer (D): 1,014 (derivative) · +3 more | EDGAR |
| 2023-02-24 | 4 | TAYLOR SCOTT C — Director | Disposition to issuer (D): 7,753 @ $18 · Disposition to issuer (D): 4,534 (derivative) · Disposition to issuer (D): 20,728 (derivative) | EDGAR |
| 2023-02-24 | 4 | TOCIO MARY ANN — Director | Disposition to issuer (D): 47,298 @ $18 · Disposition to issuer (D): 12,214 (derivative) · Disposition to issuer (D): 6,602 (derivative) · Disposition to issuer (D): 20,728 (derivative) | EDGAR |
| 2023-02-24 | 4 | DUNLEVIE BRUCE — Director | Disposition to issuer (D): 12,586 @ $18 · Disposition to issuer (D): 665,257 @ $18 · Disposition to issuer (D): 5,294 (derivative) · Disposition to issuer (D): 498 (derivative) · Disposition to issuer (D): 1,014 (derivative) · Disposition to issuer (D): 725 (derivative) · +2 more | EDGAR |
| 2023-02-17 | 4 | Thaler Bjorn B — Chief Financial Officer | Option exercise (M): 13,829 · Sale (S): 6,015 @ $15.36 · Option exercise (M): 13,829 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Mango Lisa A — General Counsel and Secretary | Option exercise (M): 11,525 · Option exercise (M): 2,221 · Sale (S): 7,596 @ $15.36 · Sale (S): 6,150 @ $15.32 · Option exercise (M): 11,525 (derivative) @ $0 · Option exercise (M): 2,221 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Diamond Andrew S — Chief Medical Officer | Option exercise (M): 11,525 · Option exercise (M): 1,776 · Option exercise (M): 11,525 (derivative) @ $0 · Option exercise (M): 1,776 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Agarwal Vikas — Chief Accounting Officer | Option exercise (M): 4,303 · Option exercise (M): 829 · Sale (S): 2,117 @ $15.36 · Option exercise (M): 4,303 (derivative) @ $0 · Option exercise (M): 829 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | Kennedy David P — Director | Grant/award (A): 751 @ $0 | EDGAR |
| 2023-01-18 | 4 | Auvil Paul R. III — Director | Grant/award (A): 1,051 @ $0 | EDGAR |
| 2023-01-18 | 4 | Agarwal Vikas — Chief Accounting Officer | Grant/award (A): 15,025 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | TAYLOR SCOTT C — Director | Grant/award (A): 751 @ $0 | EDGAR |
| 2023-01-18 | 4 | TOCIO MARY ANN — Director | Grant/award (A): 751 @ $0 | EDGAR |
| 2023-01-18 | 4 | DUNLEVIE BRUCE — Director | Grant/award (A): 1,051 @ $0 | EDGAR |
| 2023-01-05 | 4 | Thaler Bjorn B — Chief Financial Officer | Grant/award (A): 194,030 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Rubin Amir Dan — Chair, CEO and President, Director | Grant/award (A): 477,612 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Mango Lisa A — General Counsel and Secretary | Grant/award (A): 119,403 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Diamond Andrew S — Chief Medical Officer | Grant/award (A): 95,523 (derivative) @ $0 | EDGAR |
| 2022-12-21 | 4 | Thaler Bjorn B — Chief Financial Officer | Sale (S): 6,116 @ $16.72 | EDGAR |
| 2022-12-05 | 4 | Thaler Bjorn B — Chief Financial Officer | Sale (S): 200 @ $17 | EDGAR |
| 2022-11-23 | 4 | Mango Lisa A — General Counsel and Secretary | Option exercise (M): 2,500 @ $11.47 · Option exercise (M): 1,602 @ $11.56 · Sale (S): 4,102 @ $16.58 · Option exercise (M): 2,500 (derivative) @ $0 · Option exercise (M): 1,602 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | Thaler Bjorn B — Chief Financial Officer | Option exercise (M): 10,251 · Sale (S): 3,935 @ $16.81 · Sale (S): 761 @ $16.70 · Option exercise (M): 10,251 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | Diamond Andrew S — Chief Medical Officer | Option exercise (M): 8,542 · Option exercise (M): 8,542 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | Mango Lisa A — General Counsel and Secretary | Option exercise (M): 2,472 @ $12.16 · Sale (S): 2,472 @ $16.84 · Option exercise (M): 8,542 · Sale (S): 4,230 @ $16.82 · Sale (S): 4,312 @ $16.71 · Option exercise (M): 2,472 (derivative) @ $0 · +1 more | EDGAR |
| 2022-11-03 | 4 | Thaler Bjorn B — Chief Financial Officer | Option exercise (M): 10,417 @ $7.93 · Sale (S): 10,417 @ $17.10 · Option exercise (M): 10,417 (derivative) @ $0 | EDGAR |
| 2022-10-25 | 4 | Diamond Andrew S — Chief Medical Officer | Option exercise (M): 1,777 · Option exercise (M): 22,251 @ $12.16 · Option exercise (M): 45,000 @ $6.54 · Option exercise (M): 46,875 @ $4.36 · Option exercise (M): 70,085 @ $11.56 · Sale (S): 293,185 @ $17.08 · +5 more | EDGAR |
| 2022-10-25 | 4 | Mango Lisa A — General Counsel and Secretary | Option exercise (M): 1,602 @ $11.56 · Sale (S): 1,602 @ $17.08 · Option exercise (M): 1,602 (derivative) @ $0 | EDGAR |
| 2022-10-19 | 4 | Mango Lisa A — General Counsel and Secretary | Option exercise (M): 2,472 @ $12.16 · Sale (S): 2,472 @ $17.06 · Option exercise (M): 2,500 @ $11.47 · Sale (S): 2,500 @ $17.06 · Option exercise (M): 2,472 (derivative) @ $0 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2022-10-18 | 4 | Kennedy David P — Director | Grant/award (A): 730 @ $0 | EDGAR |
| 2022-10-18 | 4 | Auvil Paul R. III — Director | Grant/award (A): 1,023 @ $0 | EDGAR |
| 2022-10-18 | 4 | TAYLOR SCOTT C — Director | Grant/award (A): 730 @ $0 | EDGAR |
| 2022-10-18 | 4 | TOCIO MARY ANN — Director | Grant/award (A): 730 @ $0 | EDGAR |
| 2022-10-18 | 4 | DUNLEVIE BRUCE — Director | Grant/award (A): 1,023 @ $0 | EDGAR |
| 2022-10-12 | 4 | Thaler Bjorn B — Chief Financial Officer | Option exercise (M): 12,610 @ $7.93 · Option exercise (M): 12,610 (derivative) @ $0 | EDGAR |
| 2022-10-12 | 4 | Rubin Amir Dan — Chair, CEO and President, Director | Option exercise (M): 1,128,882 @ $4.01 · Option exercise (M): 242,235 @ $11.56 · Sale (S): 1,371,117 @ $17.03 · Option exercise (M): 1,128,882 (derivative) @ $0 · Option exercise (M): 242,235 (derivative) @ $0 | EDGAR |
| 2022-10-06 | 4 | Mango Lisa A — General Counsel and Secretary | Option exercise (M): 2,221 · Sale (S): 1,422 @ $10.26 · Option exercise (M): 19,779 @ $12.16 · Option exercise (M): 27,234 @ $11.56 · Option exercise (M): 42,500 @ $11.47 · Option exercise (M): 44,325 @ $7.77 · +6 more | EDGAR |
| 2022-10-06 | 4 | Thaler Bjorn B — Chief Financial Officer | Option exercise (M): 298,570 @ $7.93 · Sale (S): 325,575 @ $17.18 · Option exercise (M): 298,570 (derivative) @ $0 | EDGAR |
| 2022-10-06 | 4 | Rubin Amir Dan — Chair, CEO and President, Director | Option exercise (M): 1,589,798 @ $4.01 · Option exercise (M): 24,139 @ $4.01 · Sale (S): 1,613,937 @ $17.17 · Option exercise (M): 2,123,402 @ $4.01 · Sale (S): 2,123,402 @ $17.09 · Option exercise (M): 1,825,289 @ $4.01 · +7 more | EDGAR |
| 2022-09-06 | 4 | TOCIO MARY ANN — Director | Option exercise (M): 3,301 · Option exercise (M): 3,301 (derivative) @ $0 | EDGAR |
| 2022-08-16 | 4 | Agarwal Vikas — Chief Accounting Officer | Option exercise (M): 1,080 · Sale (S): 394 @ $17.14 · Option exercise (M): 1,080 (derivative) @ $0 | EDGAR |
| 2022-08-16 | 4 | Rubin Amir Dan — Chair, CEO and President, Director | Grant/award (A): 583,090 (derivative) @ $0 | EDGAR |
Recent 8-K events — 1Life Healthcare Inc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-02-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | EDGAR |
| 2022-11-02 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2022-09-07 | 8-K/A | 8.01 — Other Events | EDGAR |
| 2022-09-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-08-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-07-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-07-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ONEM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs